The molecular genetics of cervical carcinoma (original) (raw)

References

• Antinore, M. J., Birrer, M. J., Patel, D., Nader, L. & McCance, D. J. (1996). The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factor. EMBO J 15: 1950–1960.
  CAS PubMed PubMed Central Google Scholar
• Atkin, N. B., Baker, M. C. & Fox, M. F. (1989). Chromosome changes in 43 carcinomas of the cervix uteri. Cancer Genet Cytogenet 44: 229–241.
  Google Scholar
• Banks, L., Edmonds, C. & Vousden, K. H. (1995). Ability of the HPV16 E7 protein to bind Rb and induce DNA synthesis is not sufficient for efficient transforming activity in NIH3T3 cells. Oncogene 5: 1383–1389.
  Google Scholar
• Bartholomew, I. S., Glenville, S., Sarkar, S., Burt, D. J., Stanley, M. A., Ruiz-Cabello, F., Chengang, J., Garrido, F. & Stern, P. L. (1997). Integration of high-risk human papillomavirus DNA is linked to the down-regulation of class I antigens by steroid hormones in cervical tumor cells. Cancer Res 57: 937–942.
  CAS PubMed Google Scholar
• Bartsch, D., Boye, B., Baust, C., zur Hausen, H. & Schwarz, E. (1992). Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non-tumorigenic and tumorigenic HeLa hybrid cells. EMBO J 11: 2283–2291.
  CAS PubMed PubMed Central Google Scholar
• Bauer-Hoffman, R., Borghouts, C., Bourda, E., F, R. s. & Alonso, A. (1996). Genomic cloning and characterization of the nonoccupied allele corresponding to the integration site of human papillomavirus type 16 DNA in the cervical cancer cell line SiHa. Virology 217: 33–41.
  Google Scholar
• Bethwaite, P. B., Koreh, J., Herrington, C. S. & McGee, J. O. (1995). Loss of heterozygosity occurs at the D11S29 locus on chromosome 11q23. Br J Cancer 71: 814–818.
  CAS PubMed PubMed Central Google Scholar
• Bosch, F. X., Manos, M. M., Muñoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R. & Shah, K. V. (1995). Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 87: 796–802.
  CAS PubMed Google Scholar
• Braly, P. (1996). Preventing cervical cancer. Nat Med 2: 749–751.
  CAS PubMed Google Scholar
• Cannistra, S. A. & Niloff, J. (1996). Cancer of the uterine cervix. N Engl J Med 334: 1030–1038.
  CAS PubMed Google Scholar
• Castren, K., Vahakangas, K., Heikkinen, E. & Ranki, A. (1998). Absence of p53 mutations in benign and pre-malignant male genital lesions with over-expressed p53 protein. Int J Cancer 77: 674–678.
  CAS PubMed Google Scholar
• Couturier, J., Sastre-Garau, X., Schneider-Maunoury, S., Labib, A. & Orth, G. (1991). Integration of papillomavirus DNA near MYC genes in genital carcinomas and its consequences for proto-oncogene expression. J Virol 65: 4534–4538.
  CAS PubMed PubMed Central Google Scholar
• Cullen, A. P., Reid, R., Campion, M. & Campion, A. T. Lr (1991). Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasia. J Virol 65: 606–612.
  CAS PubMed PubMed Central Google Scholar
• Chen, T., Pecoraro, G. & Defendi, V. (1993). Genetic analysis of in vitro progression of human papillomavirus transfected human cervical cells. Cancer Res 53: 1167–1171.
  CAS PubMed Google Scholar
• Choo, K., Lee, H., Chong, K. & Chou, H. (1990). Analysis of the unoccupied site of an integrated human papilomavirus 16 sequence in a cervical carcinoma. Virology 178: 621–625.
  CAS PubMed Google Scholar
• Choo, K., Huang, C., Chen, C. M., Han, C. P. & Au, L. C. (1995). Jun-B oncogene aberrations in cervical cancer cell lines. Cancer Lett 93: 249–253.
  CAS PubMed Google Scholar
• Chu, T-Y, Shen, C-Y, Chiou, Y-S, Perng, C-L, Yu, M-S & Liu, H-S (1998). HPV-associated cervical cancers show frequent allelic loss at 3p14 but no apparent aberration of FHIT mRNA. Int J Cancer 75: 199–204.
  CAS PubMed Google Scholar
• Dokianakis, D. N., Sourvinos, G., Sakkas, S., Athanasiadou, E. & Spandidos, D. A. (1998). Detection of HPV and ras gene mutations in cervical smears from female genital lesions. Oncol Rep 5: 1195–1198.
  CAS PubMed Google Scholar
• Dowhanick, J. J., McBride, A. A. & Howley, P. M. (1995). Suppression of cellular proliferation by the papillomavirus E2 protein. J Virol 69: 7791–7799.
  CAS PubMed PubMed Central Google Scholar
• Durst, M., Croce, C., Gissman, L., Schwarz, E. & Huebner, K. (1987). Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci USA 84: 1070–1074.
  CAS PubMed PubMed Central Google Scholar
• El Awady, M., Kaplan, J. B. & Burk, R. D., SJ, OB (1987). Molecular analysis of integrated human papillomavirus 16 sequences in the cervical cancer cell line SiHa. Virology 159: 389–398.
  CAS PubMed Google Scholar
• Frattini, M. G., Hurst, S. D., Lim, H. B., Swaminathan, S. & Laimins, L. A. (1997). Abrogation of a mitotic checkpoint by E2 proteins from oncogenic human papillomaviruses correlates with increased turnover of the p53 tumor suppressor protein. Embo J 16: 318–331.
  CAS PubMed PubMed Central Google Scholar
• Fujita, M., Inoue, M., Tanizawa, O., Iwamoto, S. & Enomoto, T. (1992). Alterations of p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Cancer Res 52: 5323–5328.
  CAS PubMed Google Scholar
• Gallego, M. I. & Lazo, P. A. (1995). Deletion in human chromosome region 12q13–15 by integration of human papillomavirus DNA in a cervical carcinoma cell line. J Biol Chem 270: 24321–24326.
  CAS PubMed Google Scholar
• Gallego, M. I., Shoenmakers, EPFM, Van de Ven, W. J. M. & Lazo, P. A. (1997). Complex genomic rearrangement within the 12q15 multiple aberration region induced by integrated human papillomavirus 18 in a cervical carcinoma cell line. Mol Carcinogen 19: 114–121.
  CAS Google Scholar
• Gloss, B., Chong, T. & Bernard, H. (1989). Numerous nuclear proteins bind the long control region of human papillomavirus type 16: a subset of 6 of 23 DNaseI-protected segments coincides with the location of the cell-type-specific enhancer. J Virol 63: 1142–1152.
  CAS PubMed PubMed Central Google Scholar
• Greeblatt, M. S., Bennet, W. P., Hollstein, M. & Harris, C. C. (1994). Mutations in the p53 tumor suppressor genes: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855–4878.
  Google Scholar
• Greenspan, D. L., Connolly, D. C., Wu, R., Lei, R. Y., Vogelstein, J. T. C., Kim, Y., Mok, J. E., Muñoz, N., Bosch, F. X., Shah, K. & Cho, K. R. (1997). Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Cancer Res 57: 4692–4698.
  CAS PubMed Google Scholar
• Hampton, G. M., Larson, A. A., Baergen, R. N., Sommers, R. L., Kren, S. & Cavanee, W. K. (1996). Simultaneous assessment of loss of heterozygosity at multiple microsatellite loci using semi-automated fluorescence based detection: subregional mapping of chromosome 4 in cervical carcinoma. Proc Natl Acad Sci USA 93: 6704–6709.
  CAS PubMed PubMed Central Google Scholar
• Hampton, G. M., Penny, L. A., Baergen, R. N., Larson, A., Brewer, C., Liao, S., Busby-Earle, R. M. C., Williams, A. W. R., Steel, C. M., Bird, C. C., Stanbridge, E. J. & Evans, G. A. (1994). Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22–q24. Proc Natl Acad Sci USA 91: 6953–6957.
  CAS PubMed PubMed Central Google Scholar
• Hayashi, S., Tanimoto, K., Hajiro-Nakanishi, K., Kurosomi, M., Higashi, Y., Imai, K., Suga, K. & Nakachi, K. (1997). Abnormal FHIT transcript in human breast carcinomas: a clinicopathological and epidemiological analysis of 61 Japanese cases. Cancer Res 57: 1981–1985.
  CAS PubMed Google Scholar
• Helland, A., Borresen-Dale, A., Peltomaki, P., Kristensen, M., Nesland, J. M., De La Chapelle, A. & Lothe, R. A. (1997). Microsatellite instability in cervical and endometrial carcinomas. Int J Cancer 70: 499–501.
  CAS PubMed Google Scholar
• Helland, A., Karlsen, F., Due, E. U., Holm, R., Kristensen, G. & Borresen-Dale, A. (1998a). Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load. Br J Cancer 78: 69–72.
  CAS PubMed PubMed Central Google Scholar
• Helland, A., Olsen, A. O., Gjoen, K., Akselsen, H. E., Sauer, T., Magnus, P., Borresen-Dale, A. L. & Ronningen, K. S. (1998b). An increased risk of cervical intra-epithelial neoplasia grade II-III among human papillomavirus positive patients with the HLA-DQA1*0102–DQB1*0602 haplotype: a population-based case-control study of Norwegian women. Int J Cancer 76: 19–24.
  CAS PubMed Google Scholar
• Heselmeyer, K., Schröck, E., Du Manoir, S., Blegen, H., Shah, K. V., Steinbeck, R., Auer, G. & Ried, T. (1996). Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 93: 479–484.
  CAS PubMed PubMed Central Google Scholar
• Heselmeyer, K., Macville, M., Schrock, E., Blegen, H., Hellstrom, A-C, Shah, K., Auer, G. & Ried, T. (1997). Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q. Genes Chromosom Cancer 19: 233–240.
  CAS PubMed Google Scholar
• Howley, P. M. (1995). Papillomavirinae: The viruses and their replication. In Virology, Fields BN, Knipe DM and Howley PM (eds), Vol 2. pp. 2045–2076. Lippincot-Raven: Philadelphia
  Google Scholar
• Hueber, A., Zornig, M., Lyon, D., Suda, T., Nagata, S. & Evan, G. I. (1997). Requirement for the Cd95 receptor-ligand pathway in c-myc-induced apoptosis. Science 278: 1305–1309.
  CAS PubMed Google Scholar
• Huettner, P. C., Gerhard, D. S., Li, L., Gersell, D. J., Dunnigan, K., Kamarasova, T. & Rader, J. S. (1998). Loss of heterozygosity in clinical stage IB cervical carcinoma: relationship with clinical and histopathologic features. Hum Pathol 29: 364–370.
  CAS PubMed Google Scholar
• Iglesias, M., Yen, K., Gaiotti, D., Hildesheim, A., Stoler, M. H. & Woodsworth, C. D. (1998). Human papillomavirus type 16 E7 protein sensitizes cervical keratinocytes to apoptosis and release of interleukin 1a. Oncogene 17: 1195–1205.
  CAS PubMed Google Scholar
• Jeon, S. & Lambert, P. (1995). Integration of human papillomavirus type 16 DNA in the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci USA 92: 1654–1658.
  CAS PubMed PubMed Central Google Scholar
• Jeon, S., Allen-Hoffmann, B. L. & Lambert, P. F. (1995). Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 69: 2989–2997.
  CAS PubMed PubMed Central Google Scholar
• Jones, M. H. & Nakamura, Y. (1992). Deletion mapping of chromosome 3p in female genital tract malignancies using microsatellite polymorphisms. Oncogene 7: 1631–1634.
  CAS PubMed Google Scholar
• Kaelbing, M., Burk, R. D., Atkin, N. B., Johnson, A. B. & Klinger, H. P. (1992). Loss of heterozygosity on chromosome 17p and mutant p53 in HPV-negative cervical carcinomas. Lancet 340: 140–142.
  Google Scholar
• Kalantari, M., Karlsen, F., Kristensen, G., Holm, R., Hagmar, B. & Johansson, B. (1998). Disruption of the E1 and E2 reading frames of HPV16 in cervical carcinoma is associated with poor prognosis. Int J Gynecol Pathol 17: 146–153.
  CAS PubMed Google Scholar
• Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G. & Sherr, C. J. (1997). Tumor suppression at the INK4a locus mediated by the alternative reading frame product p19arf. Cell 91: 649–659.
  CAS PubMed Google Scholar
• Karlsen, F., Rabbitts, P. H., Sundresan, V. & Hagmar, B. (1994). PCR-RFLP studies on chromosome 3p in formaldehyde-fixed paraffin-embedded cervical cancer tissues. Int J Cancer 58: 787–792.
  CAS PubMed Google Scholar
• Kersemaekers, A. M., Hermans, J., Fleuren, G. J. & van de Vijver, M. J. (1998a). Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix. Br J Cancer 77: 192–200.
  CAS PubMed PubMed Central Google Scholar
• Kersemaekers, A. M., Kenter, G. G., Hermans, J., Fleuren, G. J. & van de Vijver, M. J. (1998b). Allelic loss and prognosis in carcinoma of the uterine cervix [In Process Citation]. Int J Cancer 79: 411–417.
  CAS PubMed Google Scholar
• Kim, J. W., Namkoong, S. E., Ryu, S. W., Kim, H. S., Shin, J. W., Lee, J. M., Kim, D. H. & Kim, I. K. (1998). Absence of p15INK4B and p16INK4A gene alterations in primary cervical carcinoma tissues and cell lines with human papillomavirus infection [In Process Citation]. Gynecol Oncol 70: 75–79.
  CAS PubMed Google Scholar
• Kinzler, K. W. & Vogelstein, B. (1996). Lessons from hereditary colorectal cancer. Cell 87: 159–170.
  CAS PubMed Google Scholar
• Kinzler, K. W. & Vogelstein, B. (1998). Landscaping the cancer terrain. Science 280: 1036–1037.
  CAS PubMed Google Scholar
• Kirchhoff, M., Rose, H., Petersen, B. L., Maahr, J., Gerdes, T., Lundsteen, C., Bryndorf, T., Kryger-Baggesen, N., Christensen, L., Engelholm, S. A. & Philip, J. (1999). Comparative genomic hybridization reveals a recurrence pattern of chromosomal aberrations in severe dysplasia/carcinoma in situ of the cervix and in advanced-stage cervical carcinoma. Genes Chrom Cancer 24: 144–150.
  CAS PubMed Google Scholar
• Kohno, T., Takayama, H., Hamaguchi, M., Takano, H., Yamaguchi, N., Tsuda, H., Hirohashi, S., Vissing, H., Shimizu, M., Oshimura, M. & Yokota, J. (1993). Deletion mapping of chromosome 3p in human uterine cervical cancer. Oncogene 8: 1825–1832.
  CAS PubMed Google Scholar
• Koi, M., Morita, H., Yamada, H., Satoh, H., Barrett, J. C. & Oshimura, M. (1989). Normal human chromosome 11 suppresses tumorigenicity of human cervical tumor cell line SiHa. Mol Carcinog 2: 12–21.
  CAS PubMed Google Scholar
• Konishi, H., Takahashi, T., Kozaki, K., Yatabe, Y., Mitsudomi, T., Fujii, Y., Sugiura, T. & Matsuda, H. (1998). Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers. Oncogene 17: 2095–2100.
  CAS PubMed Google Scholar
• Krammer, P. H. (1997). The tumor strikes back: new data on expression of CD95 (APO-1/FAS) receptor/ligand system may cause paradigm changes in our view on drug treatment and tumor immunology. Cell Death Diff 4: 362–364.
  CAS Google Scholar
• Ku, J-L, Kim, W-H, Park, H-S, Kang, S-B & Park, J-G (1977). Establishment and characterization of 12 uterine cervical carcinoma cell lines: common sequence variation in the E7 gene of HPV-16 positive cell lines. Int J Cancer 72: 313–320.
  Google Scholar
• Ku, W-H, Liu, I-L, Yen, M-S, Chien, C. C., Yue, C-T, Ma, Y., Chang, S., Ng, H., Wu, C. & Shen, C. (1997). Genomic deletion and p53 inactivation in cervical carcinoma. Int J Cancer 72: 270–276.
  CAS PubMed Google Scholar
• Kubbutat, M. H. G. & Vousden, K. H. (1996). Role of E6 and E7 oncoproteins in HPV-induced anogenital malignancies. Semin Virol 7: 295–304.
  CAS Google Scholar
• Kurvinen, K., Syrjänen, K. & Syrjänen, S. (1996). p53 and bcl-2 proteins as prognostic markers in human papillomavirus-associated cervical lesions. J Clin Onc 14: 2120–2130.
  CAS Google Scholar
• Larson, A. A., Kern, S., Sommers, R. L., Yokota, J., Cavenee, W. K. & Hampton, G. M. (1996). Analysis of replication error phenotypes in cervical carcinoma. Cancer Res 56: 1426–1431.
  CAS PubMed Google Scholar
• Larson, A. A., Kern, S., Curtiss, S., Gordon, R., Cavanee, W. K. & Hampton, G. M. (1997). High resolution analysis of chromosome 3p alterations in cervical cancer. Cancer Res 57: 4082–4090.
  CAS PubMed Google Scholar
• Lazo, P. A. (1988a). Human papillomaviruses in oncogenesis. BioEssays 9: 158–162.
  CAS PubMed Google Scholar
• Lazo, P. A. (1988b). Rearrangement of both alleles of human chromosome 8 in HeLa cells, one of them as a result of papillomavirus DNA integration. J Biol Chem 263: 360–367.
  CAS PubMed Google Scholar
• Lazo, P. A., Gallego, M. I., Ballester, S. & Feduchi, E. (1992). Genetic alterations by human papillomaviruses in oncogenesis. FEBS Lett 300: 109–113.
  CAS PubMed Google Scholar
• Le Beau, M. M., Drabkin, H., Glover, T. W., Gemmill, R., Rassool, F. V., McKeithan, T. W. & Smith, D. I. (1998). An FHIT tumor suppressor gene? Genes Chromosom Cancer 21: 281–289.
  CAS PubMed Google Scholar
• Leis, P. F., Stevens, K. R., Baer, S. C., Kadmon, D., Goldberg, L. H. & Wang, X. J. (1998). A c-rasHa mutation in the metastasis of a human papillomavirus (HPV)-18 positive penile squamous cell carcinoma suggests a cooperative effect between HPV-18 and c-rasHa activation in malignant progression. Cancer 83: 122–129.
  CAS PubMed Google Scholar
• Lengauer, C., Kinzler, K. W. & Vogelstein, B. (1998). Genetic instabilities in human cancers. Nature 396: 643–649.
  CAS PubMed Google Scholar
• Lopez-Borges, S., Gallego, M. I. & Lazo, P. A. (1998). Recurrent integration of papillomavirus DNA within the human 12q14–15 uterine breakpoint region in genital carcinomas [In Process Citation]. Genes Chromosomes Cancer 23: 55–60.
  CAS PubMed Google Scholar
• Mao, L., Fan, Y-H, Lotan, R. & Hong, W. K. (1996). Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. Cancer Res 56: 5128–5131.
  CAS PubMed Google Scholar
• Mitelman, F., Mertens, F. & Johansson, B. (1997). A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 15: 417–474.
  CAS PubMed Google Scholar
• Mitra, A. B., Murty, V., Li, R. G., Pratap, M., Luthra, U. K. & Chaganti, R. S. K. (1994a). Allelotype analysis of cervical carcinoma. Cancer Res 54: 4481–4487.
  CAS PubMed Google Scholar
• Mitra, A. B., Murty, V., Pratap, M., Dodhani, P. & Chaganti, R. S. K. (1994b). ERBB2 (HER2/neu) oncogene is frequently amplified in squamous carcinoma of the uterine cervix. Cancer Res 54: 637–639.
  CAS PubMed Google Scholar
• Montgomery, K., Tedford, K. L. & McDougall, J. K. (1995). Genetic instability of chromosome 3 in HPV immortalized and tumorigenic human keratinocytes. Genes Chrom Cancer 14: 97–105.
  CAS PubMed Google Scholar
• Muller, C. Y., O’Boyle, J. D., Fong, K. M., Wistuba, I. I., Biesterveld, E., Ahmadian, M., Miller, D. S., Gazdar, A. F. & Minna, J. D. (1998). Abnormalities of fragile histidine triad genomic and complementary DNA in cervical cancer: association with human papillomavirus type. J Natl Cancer Inst 90: 433–439.
  CAS PubMed Google Scholar
• Mullokandov, M. R., Kholodilov, N. G., Atkin, N. B., Burk, R. D., Johnson, A. B. & Klinger, H. P. (1996). Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papillomavirus tumor status. Cancer Res 56: 197–205.
  CAS PubMed Google Scholar
• Ning, Y., Weber, J. L., Killary, A. M., Ledbetter, D. H., Smith, J. R. & Pereira-Smith, O. M. (1991). Genetic analysis of indefinite division in human cells: evidence for a cell senescence-related gene(s) on human chromosome 4. Proc Natl Acad Sci USA 88: 5635–5639.
  CAS PubMed PubMed Central Google Scholar
• O’Connor, M. J., Tan, S., Tan, C. & Bernard, H. (1996). YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity. J Virol 70: 6529–6539.
  PubMed PubMed Central Google Scholar
• Oshimura, M., Kugoh, H., Koi, M., Shimizu, M., Yamada, H., Satoh, H. & Barrett, J. C. (1990). Transfer of a normal human chromosome 11 suppresses tumorigenicity of some but not all tumor cell lines. J Cell Biochem 42: 135–142.
  CAS PubMed Google Scholar
• Park, S., Kang, Y., Kim, B., Lee, S., Lee, E., Lee, K., Park, K. & Lee, J. (1995). Loss of heterozygosity on the short arm of chromosome 17 in uterine cervical carcinomas. Cancer Genet Cytogenet 79: 74–78.
  CAS PubMed Google Scholar
• Pinion, S. B., Kennedy, J. H., Miller, R. W. & MacLean, A. B. (1991). Oncogene expression in cervical intraepithelial neoplasia and invasive cancer of the cervix. Lancet 337: 819–820.
  CAS PubMed Google Scholar
• Pirisi, L., Yasumoto, S., Feller, M., Doniger, J. & DiPaolo, J. A. (1987). Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J Virol 61: 1061–1066.
  CAS PubMed PubMed Central Google Scholar
• Popescu, N. C. & DiPaolo, J. A. (1989). Preferential sites for viral integration on mammalian genome. Cancer Genet Cytogenet 42: 157–171.
  CAS PubMed Google Scholar
• Popescu, N. C., DiPaolo, J. A. & Amsbaugh, S. C. (1987). Integration sites of human papillomavirus 18 DNA sequences on HeLa cell chromosomes. Cytogenet Cell Genet 44: 58–62.
  CAS PubMed Google Scholar
• Popescu, N. C., Zimonjic, D. & DiPaolo, J. A. (1990). Viral integration, fragile sites and proto-oncogenes in human neoplasia. Hum Genet 44: 58–62.
  Google Scholar
• Rabbitts, T. H. (1994). Chromosomal translocations in human cancer. Nature 372: 143–149.
  CAS PubMed Google Scholar
• Rabbitts, T. H. (1997). Chromosomal breakpoints hit the spot. Nat Med 3: 496–497.
  CAS PubMed Google Scholar
• Rosl, F., Achtstatter, T., Bauknecht, T., Hutter, K. J., Futterman, G. & zur Hausen, H. (1991). Extinction of the HPV18 upstream regulatory region in cervical carcinoma cells after fusion with non-tumorigenic human keratinocytes under non-selective conditions. EMBO J 10: 1337–1345.
  CAS PubMed PubMed Central Google Scholar
• Sánchez-García, I. (1997). Consequences of chromosomal abnormalities in tumor development. Annu Rev Genet 31: 429–453.
  PubMed Google Scholar
• Sastre-Garau, X., Couturier, J., Favre, M. & Orth, G. (1995). A recurrent human papillomavirus integration site at chromosome region 12q14–15 in SW756 and SK-v cell lines derived from genital tumors. CR Acad Sci III 318: 475–478.
  CAS Google Scholar
• Saxon, P. J., Srivatsan, E. S. & Stanbridge, E. J. (1986). Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells. Embo J 5: 3461–3466.
  CAS PubMed PubMed Central Google Scholar
• Schneider, J. F., McGlennen, R. C., LaBresh, K. V., Ostrow, R. S. & Faras, A. J. (1991). Rhesus papillomavirus type 1 cooperates with activated ras in transforming primary epithelial rat cells independent of dexamethasone. J Virol 65: 3354–3358.
  CAS PubMed PubMed Central Google Scholar
• Shah, K. V. & Howley, P. M. (1995). Papillomaviruses. In Virology 2: Fields BN, Knipe DM, Howley PN Lippincot-Raven: Philadelphia 2077–2109.
  Google Scholar
• Smith, P. P., Friedman, C. L., Bryant, E. M. & McDougall, J. K. (1992). Viral integration and fragile sites in human papillomavirus immortalized human keratinocyte cell lines. Genes Chromosomes Cancer 5: 150–157.
  CAS PubMed Google Scholar
• Southern, S. A. & Herrington, C. S. (1997). Interphase karyotypic analysis of chromosomes 11, 17 and X in invasive squamous-cell carcinoma pf the cervix: Morphological correlation with HPV infection. Int J Cancer 70: 502–507.
  CAS PubMed Google Scholar
• Sozzi, G., Veronese, M. L., Negrini, M., Baffa, R., Cotticelli, M. G., Inoue, H., Pilotti, S., De Gregorio, L., Pastorino, U., Pierotti, M. A., Ohta, M., Huebner, K., Croce, C. M. & Tornielli, S. (1996). The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell 85: 17–26.
  CAS PubMed Google Scholar
• Srivasan, E. S., Misra, B. C., Venugopalan, M. & Wilczynski, S. P. (1991). Loss of heterozygosity for alleles on chromosome 11 in cervical carcinoma. Am J Hum Genet 49: 868–877.
  Google Scholar
• Steenbergen, R. D. M., Hermsen, M., Walboomers, J. M. M., Joenje, H., Arwert, F., Meijer, C. & Snijders, P. J. F. (1995). Integrated human papillomavirus type 16 and loss of heterozygosity at 11q22 and 18q21 in an oral carcinoma and its derivative cell line. Cancer Res 55: 5465–5471.
  CAS PubMed Google Scholar
• Steenbergen, R. D. M., Walboomers, J. M. M., Meijer, C., van der Raaij-Helmer, E. M. H., Parker, J. N., Chow, L. T., Broker, T. R. & Snijders, P. J. F. (1996). Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: activation of telomerase and allele loss at 3p, 10p, 11q and/or 18q. Oncogene 13: 1249–1257.
  CAS PubMed Google Scholar
• Stoppler, H., Stoppler, M. C., Johnson, E., Simbulan-Rosenthal, C. M., Smulson, M. E., lyer, S., Rosenthal, D. S. & Schlegel, R. (1998). The E7 protein of human papillomavirus type 16 sensitizes primary human keratinocytes to apoptosis. Oncogene 17: 1207–1214.
  CAS PubMed Google Scholar
• Thiagalingam, S., Lisistsyn, N. A., Hamaguchi, M., Wigler, M. H., Willson, J. K. V., Markowitz, S. D., Leach, F. S., Kinzler, K. W. & Vogelstein, B. (1996). Evaluation of the FHIT gene in colorectal cancers. Cancer Res 56: 2936–2939.
  CAS PubMed Google Scholar
• Thomas, M., Matlashewski, G., Pim, D. & Banks, L. (1996). Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV18 E6 through ubiquitin mediated degradation. Oncogene 13: 265–273.
  CAS PubMed Google Scholar
• Tomlinson, I. & Bodmer, W. (1999). Selection, the mutation rate and cancer: ensuring that the tail does not wag the tail. Nat Med 5: 11–12.
  CAS PubMed Google Scholar
• Tomlinson, I. P. M., Novelli, M. R. & Bodmer, W. F. (1996). The mutation rate and cancer. Proc Natl Acad Sci USA 93: 14800–14803.
  CAS PubMed PubMed Central Google Scholar
• Uejima, H., Mitsuya, K., Kugoh, H., Horikawa, I. & Oshimura, M. (1995). Normal human chromosome 2 induces cellular senescence in the human cervical carcinoma cell line SiHa. Genes Chromosomes Cancer 14: 120–127.
  CAS PubMed Google Scholar
• Unger, E. R., Vernon, S. D., Thoms, W. W., Nisenbaum, R., Spann, C. O., Horowitz, I. R., Icenogle, J. P. & Reeves, W. C. (1995). Human papillomavirus and disease-free survival in FIGO stage Ib cervical cancer. J Infect Dis 172: 1184–1190.
  CAS PubMed Google Scholar
• Vernon, S. D., Unger, E. R., Miller, D. L., Lee, D. R. & Reeves, W. C. (1997). Association of human papillomavirus type 16 integration in the E2 gene with poor disease-free survival from cervical cancer. Int J Cancer 74: 50–56.
  CAS PubMed Google Scholar
• Werness, B. A., Levine, A. J. & Howley, P. M. (1990). Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248: 76–79.
  CAS PubMed Google Scholar
• Wilke, C. M., Hall, B. K., Hoge, A., Paradee, W., Smith, D. I. & Glover, T. W. (1996). FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum Mol Genet 5: 187–195.
  CAS PubMed Google Scholar
• Yokota, J., Tsukada, Y., Nakajima, T., Gotoh, M., Shimosato, Y., Mori, N., Tsunokawa, Y., Sugimura, T. & Terada, M. (1989). Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix. Cancer Res 49: 3598–3601.
  CAS PubMed Google Scholar
• Yoshino, K., Enomoto, T., Nakamura, T., Nakashima, R., Wada, H., Saitoh, J., Noda, K. & Murata, Y. (1998). Aberrant FHIT transcripts in squamous cell carcinoma of the uterine cervix. Int J Cancer 76: 176–181.
  CAS PubMed Google Scholar
• Zimonjic, D. B., Popescu, N. C. & DiPaolo, J. A. (1994). Chromosomal organization of viral integration sites in human papillomavirus-immortalized human keratynocytes cell lines. Cancer Genet Cytogenet 72: 39–43.
  CAS PubMed Google Scholar
• Zimonjic, D. B., Druck, T., Ohta, M., Kastury, K., Coce, C. M., Popescu, N. & Huebner, K. (1997). Position of chromosome 3p14.2 fragile site (FRA3B) within the FHIT gene. Cancer Res 57: 1166–1170.
  CAS PubMed Google Scholar
• Zou, T. T., Lei, J., Shi, Y. Q., Wang, S., Souza, R. F., Kong, D., Shimada, Y., Smolinski, K. N., Greenwald, B. D., Abraham, J. M., Harpaz, N. & Meltzer, S. J. (1997). FHIT alterations in esophageal cancer and ulcerative colitis (UC). Oncogene 15: 101–105.
  CAS PubMed Google Scholar
• zur Hausen, H. (1994). Human papillomaviruses. Annu Rev Microbiol 48: 427–447.
  CAS PubMed Google Scholar

Download references